newsfilter
← Latest News
PR Newswire·

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, announced today the appointment of Michael Kaseta to its Board of...